Trials / Not Yet Recruiting
Not Yet RecruitingNCT06350344
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management: A Multicenter Cohort Study
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,353 (estimated)
- Sponsor
- Navy General Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Smart technologies, such as wearable devices, mobile technologies, and artificial intelligence, are being investigated for use in health management. These technologies have the potential to be applied in disease pre-warning, decision-making support, health education, and healthcare maintenance. They are expected to address the challenges in managing thrombosis, improve access to high-quality medical resources in various regions, and enhance the development of a network for thrombosis rescue and treatment prevention. The objective of this study is to observe the long-term effect of mobile venous thromboembolism application (mVTEA) based patient-centered management of venous thromboembolism (VTE) on thromboprophylaxis, and establish a foundation of evidence for managing patients with high-risk VTE.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | mobile venous thromboembolism application (mVTEA) | mVTEA will assist in the management of patients with high-risk of VTE during the post-hospitalization follow-up phase. The mVTEA's doctor terminal automatically sends VTE-related health education materials in different frequencies and contents based on the patient's knowledge of VTE prevention and treatment, as well as their risk of thrombosis and bleeding during follow-up. In addition, thrombosis physicians on the mVTEA's doctor terminal can deliver health education to patients based on their condition. This can be done through the mVTEA doctor-patient communication module, which includes text, voice, and video communication. |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2026-10-31
- Completion
- 2027-10-31
- First posted
- 2024-04-05
- Last updated
- 2024-07-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06350344. Inclusion in this directory is not an endorsement.